Skip to main content
Year archive

OPKO Health Inc. — 2026 filings

All 42 regulatory filings released by OPKO Health Inc. (OPK) in 2026, sourced directly from the official regulator.

42 Filings
2026 Period
2026 filings (42)
Filing Released Lang
Immediate Report
Proxy Solicitation & Information Statement
2026-05-16 English
Immediate Report
Report Publication Announcement
2026-05-16 English
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Regulatory Filings
2026-05-12 English
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Report Publication Announcement
2026-05-12 English
Annual Report on Form 10-K
Regulatory Filings
2026-05-01 English
Annual Report on Form 10-K
Regulatory Filings
2026-05-01 English
Additional proxy soliciting materials - definitive
Regulatory Filings
2026-05-01 English
Additional proxy soliciting materials - definitive
Regulatory Filings
2026-05-01 English
Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026.
Regulatory Filings
2026-05-01 English
Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026.
Regulatory Filings
2026-05-01 English
BioReference® Launches BioReference DirectTM, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
Regulatory Filings
2026-04-30 English
BioReference® Launches BioReference DirectTM, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
Regulatory Filings
2026-04-30 English
OPKO Health Expands Nicoya Agreement to Support RAYALDEE Commercialization in Greater China
Regulatory Filings
2026-04-30 English
OPKO Health Expands Nicoya Agreement to Support RAYALDEE Commercialization in Greater China
Regulatory Filings
2026-04-30 English
Immediate Report
Earnings Release Q1 2026
2026-04-28 English
Immediate Report
Report Publication Announcement
2026-04-28 English
Report of Periodic or Interim Report
Interim / Quarterly Report Q1 2026
2026-04-28 English
Report of Periodic or Interim Report
Report Publication Announcement
2026-04-28 English
Immediate Report
Regulatory Filings
2026-04-22 English
Immediate Report
Report Publication Announcement
2026-04-22 English
Immediate Report
Report Publication Announcement
2026-04-22 English
Immediate Report
Report Publication Announcement
2026-04-22 English
Immediate Report
Regulatory Filings
2026-04-08 English
Immediate Report
Report Publication Announcement
2026-04-08 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Director's Dealing
2026-03-21 English
Immediate Report
Board/Management Information
2026-03-19 English
Immediate Report
Report Publication Announcement
2026-03-19 English
Immediate Report
Regulatory Filings
2026-02-27 English
Immediate Report
Regulatory Filings
2026-02-27 English
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Earnings Release Q4 2025
2026-02-27 English
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Report Publication Announcement
2026-02-27 English
Form 10-K for the year ended December 31, 2025
Annual Report FY 2025
2026-02-27 English
Form 10-K for the year ended December 31, 2025
Report Publication Announcement
2026-02-27 English
Expected date for publication of Fourth Quarter 2025 Financial Results on February 26 and a conference call at 4:30PM ET
Report Publication Announcement
2026-02-12 English
Expected date for publication of Fourth Quarter 2025 Financial Results on February 26 and a conference call at 4:30PM ET
Report Publication Announcement
2026-02-12 English
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Regulatory Filings
2026-02-04 English
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Regulatory Filings
2026-02-04 English